Cart
sales@molnova.com
LSP-249
CAS No. 1801253-04-2
LSP-249( —— )
Catalog No. M23814 CAS No. 1801253-04-2
LSP-249 is a plasma kallikrein inhibitor under the study for angioedema, with an EC50 less than 100 nM in cell.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 36 | In Stock |
|
| 5MG | 58 | In Stock |
|
| 10MG | 87 | In Stock |
|
| 25MG | 177 | In Stock |
|
| 50MG | 295 | In Stock |
|
| 100MG | 484 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLSP-249
-
NoteResearch use only, not for human use.
-
Brief DescriptionLSP-249 is a plasma kallikrein inhibitor under the study for angioedema, with an EC50 less than 100 nM in cell.
-
DescriptionLSP-249 is a plasma kallikrein inhibitor under the study for angioedema, with an EC50 less than 100 nM in cell.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptorkallikrein
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1801253-04-2
-
Formula Weight431.92
-
Molecular FormulaC24H22ClN5O
-
Purity>98% (HPLC)
-
SolubilityDMSO:31.25 mg/mL?(69.45 mM;?ultrasonic and warming and heat to 60°C)
-
SMILESCc1cc(N)nc(C)c1CNC(c1cc(Cc2ccc3ncc(Cl)cc3c2)ncc1)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Andrew Mcdonald, et al. Therapeutic inhibitory compounds. Patent. WO2016011209A1.
molnova catalog
related products
-
Lucenin-1 Luteolin-6...
Lucenin 1 is a flavonoid isolated from the aerial parts of Erucaria microcarpa Boiss.
-
HPi1
HPi1 is a selective and orally active antimicrobial against Helicobacter pylori (IC50: 0.24 μM and a MIC of 0.08-0.16 μg/mL).
-
4-O-Desacetylcleomes...
Quercetin 3-O-Glc-(1→2)-Rha-7-O-Rha is a flavonol glycoside with no significant inhibitory activity against albumin oleate-induced lipid accumulation.
